桿狀病毒表達系統市場：依產品類型、應用、最終用戶和地區分類

桿狀病毒表現系統市場預計到 2026 年將達到 4.748 億美元，預計到 2033 年將達到 8.624 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.9%。

桿狀病毒表現系統是生物技術領域中用途廣泛且功能多樣的工具，用於生產重組蛋白。桿狀病毒是一類昆蟲病毒，能夠感染昆蟲細胞，並經過基因改造以表達目標外源基因。與其他表達系統相比，該系統具有許多優勢，包括高蛋白產量、轉譯後修飾以及易於規模化生產。

桿狀病毒表現系統在生物製藥生產、蛋白質研究、疫苗開發和基因治療等眾多領域都有應用。多年來，這些系統經過廣泛的研究和最佳化，效率和通用性都得到了顯著提高。

市場動態：

全球桿狀病毒表達系統市場預計在未來幾年將迎來顯著成長。推動這一成長的因素包括治療和科學研究領域對重組蛋白日益成長的需求。由於這些系統能夠高效生產複雜且功能強大的蛋白質，因此成為生物製藥行業的首選。

另一個市場促進因素是用於開發新療法和疫苗的研發活動投入不斷增加。桿狀病毒表現系統為生產這些生技藥品提供了一個可靠且經濟高效的平台。

然而，市場上也存在一些限制。其中一個主要挑戰是，利用桿狀病毒表現系統生產蛋白質的過程複雜且耗時。最佳化和擴大系統規模需要專業技術，而且非常耗費人力。

儘管如此，該市場仍蘊藏著許多成長機會。隨著人們對個人化醫療的關注度不斷提高，以及先進療法的不斷湧現，對客製化蛋白質生產系統的需求日益成長。桿狀病毒表現系統憑藉其柔軟性和生產多種蛋白質的能力，完全能夠滿足這項需求。

本報告的主要特點

• 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
• 本節根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數，對全球桿狀病毒表達系統市場的主要參與者進行介紹。
• 本報告涵蓋的主要公司包括：賽默飛世爾科技、默克集團、寶生物、安捷倫科技、牛津表達技術、普羅米加公司、凱傑公司、博雷德實驗室、新英格蘭生物實驗室、金斯瑞生物技術公司、Syngene International Limited、賽多利斯公司、Aragen Bioscience、Vivopure、Creative Biogeneals、Absolute、論文。
• 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
• 《全球桿狀病毒表達系統市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過分析全球桿狀病毒表達系統市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
    • 治療和研究用途對重組蛋白的需求不斷成長
  • 抑制因子
    • 蛋白質生產是一個複雜且耗時的過程
  • 機會
    • 隨著人們對個人化醫療的日益關注，先進治療方法的研發也不斷推進。
• 影響分析
• 主要亮點
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特五力分析
• 企業合併情景

第4章：全球桿狀病毒表現系統市場

• 供給面和需求面分析
• 經濟影響

第5章：全球桿狀病毒表現系統市場：依產品類型分類（2021-2033 年）

• 桿狀病毒
• 表達載體
• 試劑
• 其他

第6章：全球桿狀病毒表達系統市場：按應用領域分類（2021-2033 年）

• 治療
• 疫苗
• 蛋白質純化
• 其他

第7章：全球桿狀病毒表達系統市場：按最終用戶分類（2021-2033 年）

• 生物製藥公司
• 研究機構
• 其他

第8章：全球桿狀病毒表現系統市場：按地區分類（2021-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 中東和非洲
  • GCC
  • 以色列和北非
  • 中非
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• Thermo Fisher Scientific
• Merck KGaA
• Takara Bio
• Agilent Technologies
• Oxford Expression Technologies
• Promega Corporation
• Qiagen NV
• Bio-Rad Laboratories
• New England Biolabs
• Genscript Biotech Corporation
• Syngene International Limited
• Sartorius AG
• Aragen Bioscience
• Vivopure
• Creative Biogene
• Absolute Antibody
• Rockland Immunochemicals
• 蛋白質技術公司（PTI）
• Proteogenix
• Virovek

第10章

• 分析方法
• 關於 Coherent Market Insights

Baculovirus Expression System Market is estimated to be valued at USD 474.8 Mn in 2026 and is expected to reach USD 862.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

A baculovirus expression system is a highly versatile and widely utilized tool in biotechnology for the production of recombinant proteins. Baculovirus is an insect virus that infects insect cells, and they have been engineered to express foreign genes of interest. This system offers several advantages over other expression systems including high protein yields, post-translational modifications, and scalability.

The baculovirus expression system has found applications in various fields such as biopharmaceutical production, protein research, vaccine development, and gene therapy. The system has been extensively studied and optimized over the years, leading to improved efficiency and versatility.

Market Dynamics:

The global baculovirus expression system market is expected to witness significant growth in the coming years. Several factors are driving this growth, including the increasing demand for recombinant proteins for therapeutic and research purposes. The system's ability to produce high levels of complex and functional proteins has made it a preferred choice in the biopharmaceutical industry.

Another driver of the market is the rising investments in research and development activities for the development of novel therapies and vaccines. The baculovirus expression system provides a reliable and cost-effective platform for the production of these biologics.

However, the market also faces certain restraints. One of the major challenges is the complex and time-consuming process of protein production using the baculovirus expression system. The optimization and scaling-up of the system requires technical expertise and can be labor-intensive.

Nevertheless, the market presents numerous opportunities for growth. The increasing focus on personalized medicine and the development of advanced therapeutics creates a demand for customized protein production systems. The baculovirus expression system, with its flexibility and ability to produce a wide range of proteins, is well-positioned to meet this demand.

Key Features of the Study:

• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• Key players in the global baculovirus expression system market are profiled including company highlights, product portfolios, key highlights, financial performance, and strategies
• The key companies covered in this study include Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, and Virovek
• Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics
• The global baculovirus expression system market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would benefit from the strategy matrices used in analyzing the global baculovirus expression system market, making decision-making easier

Global Baculovirus Expression System Market Segmentation:

• By Product Type (Revenue, USD Mn, 2021 - 2033)
• Baculovirus
• Expression Vector
• Reagents
• Others
• By Application (Revenue, USD Mn, 2021 - 2033)
• Therapeutics
• Vaccines
• Protein Purification
• Others
• By End User (Revenue, USD Mn, 2021 - 2033)
• Biopharmaceutical Companies
• Research Institutes
• Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Top Companies in the Global Baculovirus Expression System Market:
• Thermo Fisher Scientific
• Merck KGaA
• Takara Bio
• Agilent Technologies
• Oxford Expression Technologies
• Promega Corporation
• Qiagen N.V.
• Bio-Rad Laboratories
• New England Biolabs
• Genscript Biotech Corporation
• Syngene International Limited
• Sartorius AG
• Aragen Bioscience
• Vivopure
• Creative Biogene
• Absolute Antibody
• Rockland Immunochemicals
• Protein Technologies, Inc. (PTI)
• Proteogenix
• Virovek

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Baculovirus Expression System Market, By Product Type
  • Global Baculovirus Expression System Market, By Application
  • Global Baculovirus Expression System Market , By End User
  • Global Baculovirus Expression System Market , By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
    • The increasing demand for recombinant proteins for therapeutic and research purposes
  • Restraints
    • The complex and time-consuming process of protein production
  • Opportunities
    • The increasing focus on personalized medicine and the development of advanced therapeutics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER€(TM)s Analysis
• Merger and Acquisition Scenario

4. Global Baculovirus Expression System Market

• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Baculovirus Expression System Market, By Product Type, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Baculovirus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Expression Vector
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Baculovirus Expression System Market, By Application, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Protein Purification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Global Baculovirus Expression System Market, By End User, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

8. Global Baculovirus Expression System Market, By Region, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2022 - 2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
    • U.S
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
    • U.K
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2021 - 2033, (US$ Mn)
    • GCC
    • IsraelNorth Africa
    • Central Africa
    • South Africa
    • Rest of Middle East & Africa

9. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Takara Bio
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Oxford Expression Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Promega Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Qiagen N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• New England Biolabs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Genscript Biotech Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Syngene International Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sartorius AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Aragen Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vivopure
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Creative Biogene
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Absolute Antibody
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Rockland Immunochemicals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Protein Technologies, Inc. (PTI)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Proteogenix
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Virovek
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us